Literature DB >> 10522164

When is a medical product too risky? An interview with FDA's top drug official. Interview by Tamar Nordenberg.

J Woodcock.   

Abstract

Mesh：

Year:  1999        PMID： 10522164

Source DB:  PubMed          Journal:  FDA Consum        ISSN： 0362-1332


× No keyword cloud information.
  2 in total

Review 1.  Perception of risk: the state of COX-2 selective inhibitors.

Authors:  Lee S Simon; Vibeke Strand
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 2.  Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk.

Authors:  Lawrence Goldkind; Lee S Simon
Journal:  Arthritis Res Ther       Date:  2006-03-02       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.